Clinical Trials

479 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Hepatocellular

NCT05975073 2026-04-22

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

53 enrolled

Tumor-Agnostic

Neoplasms

NCT06614140 2026-04-22

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

8 enrolled

Tumor-Agnostic

Neoplasms

NCT01682083 2026-04-21

COMBI-AD

870 enrolled 15 charts 1 FDA

Dermatologic

Melanoma, Neoplasms

NCT02296125 2026-04-21

FLAURA

674 enrolled 21 charts 1 FDA

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

NCT03578367 2026-04-21

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.

MyeloidOther hematologic neoplasm

104 enrolled 33 charts

Hematologic Diseases, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03710876 2026-04-21

INFINITE

Other solid neoplasmThoracic

53 enrolled 23 charts

Mesothelioma, Malignant

NCT04523207 2026-04-21

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

108 enrolled 13 charts

Genitourinary

Prostatic Neoplasms

NCT05376527 2026-04-21

Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact

34 enrolled 18 charts

Breast

Breast Neoplasms, Vaccinia

NCT06380361 2026-04-21

INSPECT

30 enrolled 6 charts

Lung Neoplasms

NCT06533657 2026-04-21

UTOPIA-1

11 enrolled

Cancer Pain

NCT01802632 2026-04-20

AURA

603 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT04083235 2026-04-20

NAPOLI 3

770 enrolled 13 charts 2 FDA

Metastatic Adenocarcinoma of the Pancreas

NCT05189093 2026-04-20

Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma

48 enrolled

Lymphoma

NCT05519865 2026-04-20

A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC

118 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07450833 2026-04-20

BOOST

48 enrolled 38 charts

COVID-19, Neoplasms, Korsakoff Syndrome

NCT01298323 2026-04-17

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

205 enrolled 10 charts

Neoplasm Metastasis, Carcinoma, Medullary

NCT03317743 2026-04-17

Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors

32 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT03732768 2026-04-17

Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

21 enrolled

Gynecologic

Ovarian Neoplasms, Peritoneal Neoplasms

NCT03881488 2026-04-17

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

DermatologicHead & NeckOther solid neoplasmThoracic

100 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Melanoma, Mesothelioma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT04174716 2026-04-17

VASTUS

108 enrolled

Other solid neoplasm

Solid Tumors

NCT05022849 2026-04-17

A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

15 enrolled

Genitourinary

Prostatic Neoplasms

NCT05513742 2026-04-17

COMPANION-003

49 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05848011 2026-04-17

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

MyeloidOther hematologic neoplasm

154 enrolled

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT06427811 2026-04-17

ASC4INDIA

Phase 4 Completed

85 enrolled

Bronchiolitis Obliterans Syndrome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01630733 2026-04-15

ENSPIRIT

664 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02719613 2026-04-15

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

67 enrolled

Plasma cell

Multiple Myeloma

NCT04072952 2026-04-15

mBC

217 enrolled

Breast

Breast Neoplasms

NCT04886271 2026-04-15

Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors

20 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04924062 2026-04-15

KEYNOTE-966

158 enrolled 19 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT05304936 2026-04-15

HCW9218 for Advanced Pancreatic Cancer

21 enrolled

Advanced Pancreatic Carcinoma

NCT06929195 2026-04-14

Clinical Trial to Evaluate the Tolerance of TQB2210 Injection

16 enrolled

Advanced Malignant Tumours

NCT03555422 2026-04-13

ENGOT-EN5

263 enrolled

Gynecologic

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT03957590 2026-04-13

A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma

370 enrolled 17 charts

Esophageal Squamous Cell Carcinoma

NCT04557150 2026-04-13

A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)

225 enrolled

Plasma cell

Multiple Myeloma

NCT04988750 2026-04-13

Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients

7 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT05377554 2026-04-13

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

154 enrolled

Tumor-Agnostic

Neoplasms

NCT02625480 2026-04-09

ZUMA-4

95 enrolled

Recurrence, Lymphoma, B-Cell

NCT03850873 2026-04-09

A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics

40 enrolled

Breast

Advanced Breast Cancer

NCT03984097 2026-04-09

A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)

50 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT04446416 2026-04-09

Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients

6 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT04540211 2026-04-09

SKYSCRAPER-08

461 enrolled 24 charts

Esophageal Neoplasms

NCT06159790 2026-04-09

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

218 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06902402 2026-04-09

Evaluation of Safety and Efficacy of Three Flavors of Supportan® Drink in Cancer Patients in Taiwan

123 enrolled

Neoplasms, Malnutrition

NCT03570892 2026-04-08

BELINDA

330 enrolled 10 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04049825 2026-04-08

A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL

36 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04102020 2026-04-08

VIALE-M

Other hematologic neoplasm

112 enrolled 13 charts

Leukemia, Myeloid, Acute

NCT04231448 2026-04-08

DEB

423 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT04420884 2026-04-08

iintune-1